Shuqun Cheng

34PUBLICATIONS
57CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 17, 2026
ARID1A Stimulates Notch-TLL1 Signaling to Induce Cancer-Associated Fibroblast Activation and Intrahepatic Cholangiocarcinoma Development.

|Jul 03, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

|Jan 21, 2026
Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Xiaoyun Zhang, Haozheng Cai, Wei Peng

|Nov 26, 2025
The Rac1-USP11 feedback amplification loop: a radiation-activated engine driving radioresistance in hepatocellular carcinoma.

Kaixiao Zhou, Yabo Jiang, Jiahao Guo

|Nov 04, 2025
Author Correction: Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways.

Min Li, Xuxiao He, Weixing Guo

|Oct 13, 2025
The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.

Taiyu Shang, Tianyi Jiang, Jiangqi Tan

Pageof 6

Frequent Collaborators

4 joint publications

Jing-Jing Li

3 joint publications

Xiao-Min Wang

3 joint publications

Maolin Yan

2 joint publications

Wei-Wei Pan